Head-to-head clinical analysis & difference comparison: details on mechanism of action, dosing, half-life, interactions, and maternal-fetal safety.
PERMETHRIN vs VERSED
Clinician-reviewed, head-to-head comparison of mechanism, dosing, pharmacokinetics, and safety profiles.
Last clinically reviewed: July 2026 · OpiCalc Medical Review Team
Permethrin is a type I pyrethroid that acts on the nervous system of parasites by prolonging the inactivation of sodium channels, leading to repetitive neuronal firing and paralysis.
Benzodiazepine that enhances GABA-A receptor activity, increasing chloride ion conductance and causing neuronal hyperpolarization.
Treatment of scabies,Treatment of head lice,Treatment of pubic lice (crabs)
Sedation,Anxiolysis,Amnesia,Induction of anesthesia,Maintenance of anesthesia,ICU sedation,Status epilepticus (off-label)
For scabies: Apply 5% cream to entire body from neck to soles of feet, leave on for 8–14 hours, then wash off. For head lice: Apply 1% lotion to damp hair, leave on for 10 minutes, then rinse. Repeat in 7–10 days if necessary.
IV: Initial 1-2.5 mg; titrate by 0.5-1 mg every 2-3 min; usual total 2.5-5 mg for sedation. IM: 0.07-0.08 mg/kg (max 5 mg) once. Oral: 7.5-15 mg once (preoperative).
The terminal elimination half-life is approximately 12-17 hours in healthy adults. In children and elderly patients, half-life may be prolonged due to reduced esterase activity, with values up to 24 hours.
Terminal elimination half-life: 1.8–2.5 hours in healthy adults; prolonged in elderly (up to 6 hours), obesity (up to 8 hours), hepatic cirrhosis (up to 20 hours), and critically ill patients.
Permethrin is primarily metabolized by ester hydrolysis to inactive metabolites, with minor contributions from cytochrome P450 enzymes.
Hepatic via CYP3A4 isoenzymes; major metabolites include midazolam glucuronide (inactive) and alpha-hydroxymidazolam (active).
Permethrin is extensively metabolized via ester hydrolysis and oxidation. Metabolites are excreted primarily in the urine (approximately 70-80% of the dose) as glucuronide and sulfate conjugates, with lesser amounts in feces (20-30%). Less than 2% is excreted unchanged.
Renal: ~1% unchanged; Hepatic metabolism to glucuronide conjugates and 1-hydroxymidazolam, with subsequent renal elimination of metabolites. Fecal excretion is minimal (<2%).
Approximately 90-95% bound to plasma proteins, primarily albumin and alpha-1-acid glycoprotein.
97% bound primarily to albumin.
Apparent volume of distribution is 2-6 L/kg, indicating extensive tissue distribution, particularly to skin, fat, and brain. High Vd supports prolonged cutaneous retention.
1–1.5 L/kg (0.5–1.2 L/kg in adults); increased in obesity and hepatic disease, indicating extensive tissue distribution.
Topical: Systemic absorption is <2% of the applied dose. Oral: Bioavailability is approximately 60-70% due to first-pass metabolism. Permethrin is not administered orally for clinical use.
IM: 90%±; Oral: 40–50% (range 30–70%); Intranasal: ~75%; Rectal: ~50%.
No dosage adjustment required for any degree of renal impairment.
e GFR 10-50 m L/min: No dose adjustment needed but monitor for prolonged sedation. e GFR <10 m L/min: Consider 50% dose reduction and monitor closely.
No dosage adjustment required for any Child-Pugh class.
Child-Pugh A: No adjustment. Child-Pugh B: Reduce dose by 50%. Child-Pugh C: Avoid use or reduce dose by 75%.
For scabies in infants and children: 5% cream applied as in adults, including face, scalp, and ears (avoid eyes and mouth). For head lice in children ≥2 months: 1% lotion applied as in adults.
Neonates: IV 0.05-0.1 mg/kg; max 0.15 mg/kg. Children: IV 0.025-0.05 mg/kg (max 2 mg); titrate. Oral 0.25-0.5 mg/kg (max 20 mg) for sedation. IM 0.07-0.08 mg/kg.
No specific dosage adjustment; use standard adult dosing. Caution in elderly with extensive dermatitis due to increased percutaneous absorption.
IV: Initial 0.5-1 mg over 2 minutes; titrate slowly; max total dose 3.5 mg. Oral: 5 mg preoperatively. Reduced clearance necessitates careful titration.
No FDA black box warning.
Intravenous administration may cause respiratory depression and arrest, especially when used with opioids. Resuscitation equipment and skilled personnel must be available. Do not administer by rapid bolus injection.
Seizure risk, especially in children,Hypersensitivity reactions,Avoid contact with eyes and mucous membranes,Use with caution in patients with skin conditions (e.g., atopic dermatitis)
Respiratory depression, hypotension, paradoxical reactions, dependence and withdrawal, use in elderly or debilitated patients, hepatic/renal impairment, myasthenia gravis, glaucoma, pregnancy (category D).
Hypersensitivity to permethrin or any component of the formulation,Hypersensitivity to chrysanthemums or other pyrethroids
Known hypersensitivity to benzodiazepines, acute narrow-angle glaucoma, severe respiratory insufficiency (COPD), pregnancy (labor and delivery), breastfeeding (caution).
No known food interactions. Permethrin is applied topically and does not have systemic absorption that would be affected by food. Avoid ingestion; if accidentally ingested, seek medical attention immediately.
Grapefruit juice inhibits CYP3A4 and can significantly increase midazolam plasma concentrations, prolonging sedation and respiratory depression. Avoid grapefruit products for at least 24 hours before and after administration. High-fat meals may reduce absorption rate but not extent, though clinical significance is minimal.
Permethrin is a pyrethroid insecticide with low teratogenic potential. In animal studies at doses up to 400 mg/kg/day (maternal toxic doses), no fetal malformations were observed. Human data from topical use during pregnancy (including first trimester) do not indicate increased risk of major congenital anomalies. However, systemic absorption is minimal (<2% with topical application). The FDA assigns pregnancy category B. No specific known fetal risks by trimester.
Midazolam is classified as FDA Pregnancy Category D. There is evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans. First trimester exposure may be associated with an increased risk of congenital malformations (e.g., cleft palate). Second and third trimester exposure may cause fetal CNS depression, respiratory depression, and withdrawal symptoms (floppy infant syndrome). Use during labor may cause neonatal respiratory depression and hypotonia. Maternal hypotension and decreased uterine blood flow may occur.
Permethrin is excreted into breast milk in minimal amounts after topical application (M/P ratio not established). Based on low systemic absorption, it is considered compatible with breastfeeding. Use with caution; avoid application to breast area to minimize infant oral exposure.
Midazolam is excreted in human breast milk in low concentrations. The milk-to-plasma (M/P) ratio is approximately 0.05 to 0.15. Relative infant dose is estimated to be <1% of maternal weight-adjusted dose. Due to potential for accumulation and CNS effects in the neonate, caution is advised; alternative agents with shorter half-lives and no active metabolites are preferred. Use only if clearly needed and monitor infant for sedation, poor feeding, and respiratory depression.
No dose adjustment is necessary in pregnancy. Pharmacokinetic changes (increased volume of distribution, decreased plasma protein binding) are not clinically significant due to minimal systemic absorption of topical permethrin. Use standard dosing as in non-pregnant adults.
No specific standardized dose adjustments are established for pregnancy. Due to increased volume of distribution and altered protein binding, higher or more frequent doses may be required to achieve the same clinical effect. However, increased sensitivity to CNS depression and respiratory depression in pregnancy may offset this, requiring careful titration. Avoid use in first trimester if possible. Use lowest effective dose for shortest duration. During labor, use reduced doses due to potential for fetal accumulation and neonatal respiratory depression.
Permethrin is a synthetic pyrethroid used as a first-line topical treatment for scabies and lice. Apply from neck to toes for scabies, leave on for 8-14 hours; for lice, apply to dry hair and rinse after 10 minutes. Avoid use on open wounds or mucous membranes. Resistance is rare but reported; consider alternative if no response after two treatments. Can cause mild burning or stinging; antihistamines may help pruritus post-treatment.
Midazolam (Versed) is a short-acting benzodiazepine used for procedural sedation, pre-anesthetic medication, and status epilepticus. It has amnestic properties. Onset is rapid (1-2 min IV, 15-30 min IM). Flumazenil is the reversal agent. Caution in elderly, hepatic impairment, and respiratory compromise. CYP3A4 inhibitors (e.g., macrolides, azole antifungals, grapefruit juice) increase levels. Not recommended for prolonged sedation in ICU due to active metabolites and accumulation.
Apply permethrin to clean, dry skin or hair as directed.,For scabies, cover entire body from neck to soles of feet; avoid eyes, mouth, and nose.,Leave cream on for 8-14 hours (overnight) before washing off.,For lice, apply to dry hair, leave for 10 minutes, then rinse and use a fine-toothed comb.,Do not use more than once a week; two treatments may be needed 7 days apart.,Wash all clothing, bedding, and towels in hot water and dry on high heat.,Avoid sexual contact until treatment is complete and symptoms resolve.,Notify sexual partners and close contacts to seek evaluation and treatment.,Do not share personal items like combs, hats, or clothing.,Itching may persist for up to 2 weeks after successful treatment; do not retreat unless live mites or nits are seen.
You may experience drowsiness, dizziness, or amnesia after receiving this medication.,Do not drive or operate heavy machinery for at least 24 hours after the procedure.,Avoid alcohol for at least 24 hours after receiving midazolam.,Grapefruit and grapefruit juice may increase the effects of midazolam; avoid consumption.,Inform your healthcare provider if you are pregnant, breastfeeding, or have a history of glaucoma or breathing problems.
"Permethrin, a CYP3A4 inhibitor, may decrease the metabolism of doxycycline, a CYP3A4 substrate, leading to increased doxycycline plasma concentrations. This can potentiate doxycycline's adverse effects, particularly gastrointestinal disturbances and photosensitivity. Clinically, patients may experience enhanced risk of esophageal irritation, nausea, and sunburn-like reactions."
"Mitotane, an adrenolytic agent used in adrenocortical carcinoma, is a potent inducer of cytochrome P450 (CYP) enzymes and P-glycoprotein (P-gp). This induction can significantly reduce the systemic exposure of permethrin, a pyrethroid insecticide metabolized primarily by CYP450 isoforms. Decreased permethrin concentrations may lead to reduced efficacy in treating scabies or lice, potentially requiring dose adjustments or alternative therapies."
"Permethrin, a pyrethroid insecticide, is primarily metabolized by hepatic esterases and cytochrome P450 (CYP) enzymes, including CYP3A4. Saquinavir, a protease inhibitor used in HIV treatment, is extensively metabolized by CYP3A4. Co-administration of permethrin may competitively inhibit CYP3A4, leading to decreased saquinavir clearance, elevated plasma concentrations, and increased risk of saquinavir-related toxicities such as QT prolongation, hepatotoxicity, and gastrointestinal disturbances."
No interactions on record
Common clinical questions about PERMETHRIN vs VERSED, answered by our medical review team.
PERMETHRIN is a Scabicidal / Pediculicidal that works by Permethrin is a type I pyrethroid that acts on the nervous system of parasites by prolonging the inactivation of sodium channels, leading to repetitive neuronal firing and paralysis.. VERSED is a Benzodiazepine that works by Benzodiazepine that enhances GABA-A receptor activity, increasing chloride ion conductance and causing neuronal hyperpolarization.. They differ in pharmacokinetic profiles, FDA-approved indications, and side effect profiles.
Potency comparisons between PERMETHRIN and VERSED depend on the specific clinical indication. These are agents from distinct pharmacological classes and are not directly interchangeable by dose. A physician or clinical pharmacist should guide any therapeutic switching decisions.
The standard adult dose of PERMETHRIN is: For scabies: Apply 5% cream to entire body from neck to soles of feet, leave on for 8–14 hours, then wash off. For head lice: Apply 1% lotion to damp hair, leave on for 10 minutes, then rinse. Repeat in 7–10 days if necessary.. The standard adult dose of VERSED is: IV: Initial 1-2.5 mg; titrate by 0.5-1 mg every 2-3 min; usual total 2.5-5 mg for sedation. IM: 0.07-0.08 mg/kg (max 5 mg) once. Oral: 7.5-15 mg once (preoperative).. Dosing should always be individualized based on indication, renal and hepatic function, age, and other patient factors.
No direct drug-drug interaction has been formally documented between PERMETHRIN and VERSED in current clinical databases. However, individual patient risk factors including other medications, organ function, and comorbidities should always be evaluated by a qualified healthcare provider.
The maternal-fetal safety profiles differ. PERMETHRIN is classified as Category A/B. Permethrin is a pyrethroid insecticide with low teratogenic potential. In animal studies at doses up to 400 mg/kg/day (maternal toxic doses), no fetal malformations were observed. . VERSED is classified as Category C. Midazolam is classified as FDA Pregnancy Category D. There is evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in. Always consult a maternal-fetal medicine specialist before taking either drug during pregnancy or lactation.